A nicotine inhaler device, similar to an e-cigarette, has been licenced as a medicine in the UK.
The Voke Inhaler, developed by Kind Consumer and British American Tobacco, received a product licence from the Medicines and Healthcare products Regulatory Agency (MHRA) last week.
Voke is licensed for use to relieve and to prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. It is indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them.
Dr Chris Moyses, Chief Medical Officer, Kind Consumer, said “The Voke Inhaler has been licensed in the UK as a medicinal product after a detailed review process by the MHRA. The technology contains no electronics, heat or combustion and will rival e-cigarettes and nicotine-replacement therapies when launched.”
The decision to licence the product will allow patients trying to quit smoking to receive it on the NHS.